-- James Woodruff Lillie, Chief Scientific Officer, on May 04, 2026, sold 51,707 shares in Maplight Therapeutics (MPLT) for $1,468,251. Following the Form 4 filing with the SEC, Lillie has control over a total of 243,450 voting common shares of the company, with 243,450 shares held directly.
SEC Filing: